Navigation Links
Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
Date:11/12/2008

PARSIPPANY, N.J., Nov. 12 /PRNewswire/ -- Ferring Pharmaceuticals Inc. announces the promotion of William N. Garbarini, Jr. to Vice President of its new Orthopaedics and Urology Business Unit, recently formed by merging these clinical product areas. Garbarini was formerly Executive Director of Ferring's Orthopaedics Business Unit.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081112/NY45502 )

In his new role, Garbarini is responsible for Ferring's two marketed products in these areas, euflexxa(R) (1% sodium hyaluronate) for the pain caused by knee osteoarthritis, and PROSED(R) DS for the relief of discomfort of the lower urinary tract. He will also oversee the U.S. sales and marketing of Ferring's pipeline of urology products, including a GnRH antagonist for prostate cancer.

"Bill's exceptional talent, leadership and wealth of experience in pharmaceutical marketing have driven his rapid rise and recognition in the health care industry," said Wayne Anderson, President of Ferring. "After spearheading the growth of our infertility and orthopaedics businesses, he is extremely qualified to lead our new Orthopaedics and Urology unit."

During his tenure, Garbarini directed the launches of three key products in the Ferring portfolio. After joining Ferring in 2001 as a Product Director for its infertility franchise, he launched BRAVELLE(R), a highly purified, human-derived follicle-stimulating hormone (hFSH) for infertility treatment. Ferring quickly became a formidable player in the market and grew to become the leader in total infertility prescriptions.

Garbarini was soon promoted to the unit's Director of Marketing and oversaw the launch of MENOPUR(R) (menotropins for injection, USP), a purified human menopausal gonadotropin (hMG) for patients undergoing in vitro fertilization (IVF). The product grew Ferring's hMG segment and continued the Company's d
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest
2. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
3. Increase in Diagnostic Imaging Fueled by Self-Referring Doctors
4. Ferring Pharmaceuticals EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic
5. Dr. Jan Linhart Now Offerring Unique Laser Teeth Whitening System
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... New York, NY (PRWEB) April 27, 2015 ... Jimmy Buffett tickets at the Alpine Valley Music ... in the Elkhart, Wisconsin and Albuquerque, New Mexico area ... in their neck of the woods. Buffett will ... News in Wisconsin. His tour stops during the ...
(Date:4/27/2015)... 2015 Telematics Berlin is Europe’s biggest ... associations, CE players and the government to discuss the ... the car. This year’s panel on connected car security ... European Commission, is an opportunity to hear and contribute ... European Automotive Security Standard for years to come. ...
(Date:4/27/2015)... The global coagulation analyzers market is ... developed countries; however, it is expected to witness ... India and Brazil in the next five years. ... by factors such as increasing adoption of automated ... hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers ...
(Date:4/27/2015)... April 27, 2015 Attorney Dan Newlin, of ... serving and protecting his clients, took that commitment to a ... dialing code which makes it easier for existing and potential ... on building his brand and added value to the firm’s ... Chicago area where Newlin has law offices. , “I knew ...
(Date:4/27/2015)... Volpara Solutions today announced the release ... of Breast Imaging’s SBI/ACR Breast Imaging Symposium in ... VolparaDensity, the first breast density assessment tool ... datasets from multiple manufacturers, is already in use ... , The latest version of VolparaDensity ...
Breaking Medicine News(10 mins):Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 2Health News:Telematics Berlin: European Commission discuss a pan European Automotive Security Strategy 3Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Dan Newlin Hashtags It With #Dan 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... at the Center for Translational Social Neuroscience (CTSN) at ... new model to screen the effectiveness of drugs to ... a drug Emory researchers have shown enhances behavioral therapy ... voles. Giving female voles D-cycloserine, which is thought to ...
... DETROIT A new Henry Ford Hospital study takes a ... most serious side-effects of ACE inhibitor use facial, tongue ... invasive course of treatment. Using a treatment ... and promptly treated to reduce swelling, resulting in no tracheotomies ...
... radiation oncologist practiced were two factors that strongly influenced the ... according to an article published April 29 online in ... of IMRT and the cost of radiation therapy increased sharply ... radiation delivery technique that modulates the radiation beams to conform ...
... HealthDay Reporter , WEDNESDAY, April 27 (HealthDay News) -- The ... a new claim to fame: leprosy. A new ... and have somehow passed the disease to several dozen humans ... long-suspected link between leprosy in humans and armadillos," said the ...
... April 27 (HealthDay News) -- If you suffer a heart attack ... having one at any other time of day, a Spanish research ... 6 a.m. and noon, it is likely to damage about 20 ... afternoon or evening, the researchers added. "It is well-known for ...
... under adult supervision does not appear to teach responsible drinking ... may actually lead to more drinking and alcohol-related consequences, according ... the Journal of Studies on Alcohol and Drugs . ... according to the study,s lead researcher, Barbara J. McMorris, Ph.D., ...
Cached Medicine News:Health News:Social bonding in prairie voles helps guide search for autism treatments 2Health News:Social bonding in prairie voles helps guide search for autism treatments 3Health News:Study targets treatment for serious ACE inhibitor side effect 2Health News:Use of costly breast cancer therapy strongly influenced by reimbursement policy 2Health News:Armadillos Give Leprosy to Humans in Southern U.S.: Study 2Health News:Armadillos Give Leprosy to Humans in Southern U.S.: Study 3Health News:Morning Heart Attacks Cause More Damage, Study Finds 2Health News:Morning Heart Attacks Cause More Damage, Study Finds 3Health News:Adult-supervised drinking in young teens may lead to more alcohol use, consequences 2
(Date:4/27/2015)... , April 27, 2015   AMC Health , ... showcase advances in monitored care that are transforming chronic ... ATA 2015 Conference, May 2-5 at the ... Health will share information about how their innovative ... help transform and personalize healthcare delivery at Booth #2116 ...
(Date:4/27/2015)... NEW YORK , April 27, 2015 ... claims against the board of directors of Aerie Pharmaceuticals, ... concerning whether the board has breached its fiduciary duties ... Company issued a press release announcing results from its ... things, the press release disclosed that in the trial, ...
(Date:4/27/2015)... 2015  USL di Reggio Emilia, the Regional Health ... has implemented Zebra Technologies Corporation (NASDAQ: ... Wireless Network Solution (WNS) provided by Zebra has ... in real time via mobile computers, contributing to improved ... also provides employee and guest Wi-Fi access and enables ...
Breaking Medicine Technology:AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 2Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 3Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 4Zebra Technologies' Wireless Solutions Help Reggio Emilia Hospital Staff Improve Patient Care and Reduce Costs 5
... NEW YORK, Nov. 9 /PRNewswire-Asia-FirstCall/ -- American Oriental,Bioengineering, Inc. ... pharmaceutical,company dedicated to improving health through the development, manufacture ... the counter ("OTC"),products, today announced that it plans to ... 2009, after the market closes. , ...
... 9, 2009 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) today ... , Arena reported a lower net loss allocable to common stockholders ... per share, compared to a net loss allocable to common stockholders ... per share, and a net loss allocable to common stockholders in ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9
... offers a range of standard, enhanced ... delivers therapy to meet the needs ... in commercial and clinical effectiveness and ... the SleepStyle 200 series is the ...
... The ResMed S6 Lightweight II CPAP ... microprocessor-controlled motor that maintains consistent pressure. ... and adjusting the settings easy, and ... and make adjustments is simple. This ...
The S8 Escape is the economy model of ResMeds S8 series. The S8 Escape is ideal for patients who want the convenience and portability of the S8 models but do not require the added comfort features of...
The S7 Elite is the premium device in ResMeds award-winning S7 series. All S7 devices include an option of integrated humidification....
Medicine Products: